Targeted Therapy
Gefitinib 250 mg Tablets
EGFR inhibitor for non-small cell lung cancer.
Prescription required. This medicine is supplied only against a valid prescription from a registered oncologist.
| Generic Name / Composition | Gefitinib |
|---|---|
| Strength | 250 mg |
| Dosage Form | Tablet |
| Pack Size | 30 Tablets |
| Category | Targeted Therapy |
| Price | Available on request |
Product Information
Gefitinib is an EGFR tyrosine kinase inhibitor used in the treatment of locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations.
Information provided is for reference only. Always follow the advice of your treating doctor.
